Medios AG (ILM1) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medios AG (ILM1) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€10.96 Million ≈ $12.81 Million USD) by net assets (€519.70 Million ≈ $607.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medios AG defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Medios AG - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Medios AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medios AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medios AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Precious Shipping Public Company Limited
BK:PSL-R
|
0.038x |
|
Shenzhen Sine Electric Co. Ltd. A
SHG:688395
|
0.031x |
|
Vodafone Group PLC
LSE:VOD
|
0.163x |
|
BMTC Group Inc
TO:GBT
|
0.006x |
|
D-Link Corp
TW:2332
|
-0.022x |
|
Omega Flex Inc
NASDAQ:OFLX
|
0.007x |
|
Reconnaissance Energy Africa Ltd
V:RECO
|
-0.010x |
|
Corem Property Group AB (publ)
ST:CORE-PREF
|
0.001x |
Annual Cash Flow Conversion Efficiency for Medios AG (2010–2025)
The table below shows the annual cash flow conversion efficiency of Medios AG from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Medios AG (ILM1) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €514.22 Million ≈ $601.18 Million |
€43.00 Million ≈ $50.27 Million |
0.084x | -42.08% |
| 2024-12-31 | €510.19 Million ≈ $596.47 Million |
€73.67 Million ≈ $86.12 Million |
0.144x | +312.59% |
| 2023-12-31 | €468.81 Million ≈ $548.08 Million |
€16.41 Million ≈ $19.18 Million |
0.035x | -57.76% |
| 2022-12-31 | €448.05 Million ≈ $523.81 Million |
€37.12 Million ≈ $43.40 Million |
0.083x | -46.92% |
| 2021-12-31 | €394.16 Million ≈ $460.82 Million |
€61.52 Million ≈ $71.92 Million |
0.156x | +158.32% |
| 2020-12-31 | €142.43 Million ≈ $166.51 Million |
€-38.12 Million ≈ $-44.56 Million |
-0.268x | -4762.04% |
| 2019-12-31 | €81.63 Million ≈ $95.43 Million |
€-449.29K ≈ $-525.26K |
-0.006x | +87.62% |
| 2018-12-31 | €70.50 Million ≈ $82.42 Million |
€-3.14 Million ≈ $-3.67 Million |
-0.044x | -348.97% |
| 2017-12-31 | €45.68 Million ≈ $53.40 Million |
€816.00K ≈ $953.99K |
0.018x | +138.51% |
| 2016-12-31 | €34.10 Million ≈ $39.86 Million |
€-1.58 Million ≈ $-1.85 Million |
-0.046x | +84.92% |
| 2015-12-31 | €323.78K ≈ $378.53K |
€-99.64K ≈ $-116.49K |
-0.308x | -- |
| 2014-12-31 | €0.00 ≈ $0.00 |
€13.30K ≈ $15.55K |
x | -- |
| 2013-12-31 | €7.81K ≈ $9.13K |
€103.36K ≈ $120.84K |
13.241x | +10691.51% |
| 2012-12-31 | €172.97K ≈ $202.22K |
€21.22K ≈ $24.81K |
0.123x | +157.35% |
| 2011-12-31 | €376.75K ≈ $440.46K |
€-80.60K ≈ $-94.23K |
-0.214x | -1872.06% |
| 2010-12-31 | €341.07K ≈ $398.75K |
€-3.70K ≈ $-4.33K |
-0.011x | -- |
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and p… Read more